For the week ending June seventh, Afrezza scripts arrived in at 669. With just some months still left in the next quarter, scripts are monitoring at just twelve% better than the sub-par performance of Q1. The earnings story is tracking slightly improved, but is also very little to make more than enough self-confidence to generally be reflected duri

Article Under Review